- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03486795
Dual Site-Dual Channel Non-invasive Brain Stimulation for Motor Function in Healthy Subjects
September 19, 2019 updated by: Samsung Medical Center
Effect of Dual Site-Dual Channel Non-invasive Brain Stimulation for Recovery of Motor Function in Healthy Subjects
The aim of this study is to investigate the effect of dual site-dual channel non-invasive brain stimulation for recovery of motor function in healthy subjects.
Simultaneous dual site-dual channel stimulation was applied by using two sets of transcranial direct current stimulation devices.
All subjects will go through four conditions of transcranial direct current stimulation with for 30 minutes.
Four conditions are 1) Dual stimulation: i) anodal stimulation on right primary motor cortex and cathodal stimulation on left primary motor cortex, ii) anodal stimulation on right premotor cortex and cathodal stimulation on left supraorbital area.
2) M1 stimulation: anodal stimulation on right primary motor cortex and cathodal stimulation on left primary motor cortex; 3) PMC stimulation: anodal stimulation on right premotor cortex and cathodal stimulation on left supraorbital area.
4) sham stimulation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy subjects with age over 19 years old
Exclusion Criteria:
- history of disorders involving central nervous system
- patients with severe medial or psychiatric disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Dual stimulation
|
stimulating primary motor cortex with anodal stimulation on right primary motor cortex and cathodal stimulation on left primary motor cortex
|
EXPERIMENTAL: M1 stimulation
anodal stimulation on right primary motor cortex and cathodal stimulation on left primary motor cortex
|
stimulating primary motor cortex with anodal stimulation on right primary motor cortex and cathodal stimulation on left primary motor cortex
|
EXPERIMENTAL: PMC stimulation
anodal stimulation on right premotor cortex and cathodal stimulation on left supraorbital area
|
stimulating premotor cortex with anodal stimulation on right premotor cortex and cathodal stimulation on left supraorbital area
|
SHAM_COMPARATOR: Sham stimulation
|
sham stimulation over both primary motor cortex and premotor cortex
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in motor evoked potential
Time Frame: Baseline and after intervention (approximately 30 minutes)
|
measure the motor threshold and amplitude of motor evoked potential in first dorsal interosseous muscle
|
Baseline and after intervention (approximately 30 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in sequential motor task
Time Frame: Baseline and after intervention (approximately 30 minutes)
|
measures motor functional and dexterity of hand
|
Baseline and after intervention (approximately 30 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 31, 2017
Primary Completion (ACTUAL)
May 10, 2018
Study Completion (ACTUAL)
May 10, 2018
Study Registration Dates
First Submitted
March 22, 2018
First Submitted That Met QC Criteria
April 1, 2018
First Posted (ACTUAL)
April 3, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 20, 2019
Last Update Submitted That Met QC Criteria
September 19, 2019
Last Verified
March 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 2017-08-124-C
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on M1 stimulation
-
Sheba Medical CenterSuspended
-
The Hong Kong Polytechnic UniversityNot yet recruitingChronic Pain | Insomnia
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingDepression | Neuropathic PainFrance
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Beijing HospitalUnknownCerebrovascular DiseaseChina
-
Aalborg UniversityDanish National Research FoundationCompletedAcute Pain | Neuroplasticity | Brain Modulation | Somatosensory FunctionDenmark
-
Samsung Medical CenterCompletedStrokeKorea, Republic of
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
Guangzhou Virotech Pharmaceutical Co., Ltd.Not yet recruiting